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S ry Adequate tumour models are a preqste in rimental cancer rsarch. The purpose of the
prst work was to taablsh and asess the valty of four new orthotopic human melanoma xenograft
model systems (A-07, D-12, R-18, U-25). Pomnent cell lines we established in monolayer clture from
metastases of four diffe nt melaoma patients by usin an in vivo-i vitro and clls
from the lines wre ted intradrmally in Balb/c nulnu mice to form tumours. Individual xenogafted
tumours of the same ine differed substanIally in growth and pathophysilogical parameters, as a
consmeqz of es n inoculato its in host fatos which influence tumour an eso
Nevertheless, xenografted tumows of diffent is showed distinctly different bioogical haaisti
Seal biological of the donor patEnts' tumours we rtained in the xenogafted tumoms,
incig ango ic pontl; gowth, i ol and pathophysiological parametes; and senstiity to
heat and dacarbazine ttment. Moreover, the organ-specific patten of the xenogrfted
tumours Irted the pattern ofdistant m stases in the donor nts The organs of prefernc for distant
metastass were lungs (A-07, D-12), lymph nodes (R-18) and brain (U-25). R-18 lymph node metastas and
U-25 brAin nmnastases in the abse of lung involement The four orthotopic human meanoma
xcnograft model systems show gat promise for fuctur studies of tumour ang esis, pathophysio ,
atment sensitivity and metatatic pattem
Advances in cancer research require appropriate xperimental
models to explore basic nisms affecing the cinical
behaviour and treatment sensitivity of tumours. Human
models are usually ferable to rodent modls; expmental
rodent tumours are at best general models of human cancer
(Denekamp, 1979), whereas experimental human tumours are
supposed to model adequately the secific neoplastic disease
of the donor patient (Suthrlrand et al., 1988). The
availability of congenitally athymic mice and severe com-
bined immune deficiency mice has resulted in increased use of
human tumour xenografts in cancer research the last two
decades. Recent studies have indicated that orthotopic
heterotransplantation of human tumours may result in
metastatic patterns in mice similar to those observed in man
(Fidler, 1991; Fu et al., 1991). Moreover, cellular treatment
sensitivity is probably retained during serial transplantation
of some human tumours in immune-deficient mice (Rofstad,
1992a).
No single xenograft model can be expected to be appropri-
ate for all types of questions related to a specific neoplastic
disease; a panel of models of the same histopathological type
is required (Kallman et al., 1985). A xenograft panel is
parficularly useful if it is composed of tumour lines that
differ substantially in their biological characteristics and at
the same time reflt the biology of the donor patients'
tumours. Moreover, the xenografted tumours should have
disaggregation and growth properties making them suitable
for studies in vitro as well as in vivo.
Four new orthotopic human melanoma xenograft model
systems for studies of tumour angiogenesis, pathophysiology,
treatment sensitivity and metastatic pattern are reported in
the present communication. Tumour treatment sensitivity
and metastatic pattern are governed by intrinsic properties of
the tumour cells (Sutherland et al., 1988; Hill. 1990), but are
strongly modified by angiogenic and pathophysiological
parameters of the tumour tissue (Folkman, 1985; Vaupel et
al., 1989). The validity of the model systems was assed by
comparing essential biological characteristics of donor
patients' tumours and derivative xenografted tumours.
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MateIa aud m
Dono patins' tumours
Four Caucasian patients (A-07, D-12, R-18, U-25) admitted
to The Norwegian Radium Hospital for the treatment of
malignant melanoma were donors of tumour tissue (Table I).
The patients had developed regional metastases at the time of
initial diagosis. The R-18 patient presented with extensive
metastatic deposits also in distant lymph nodes. The other
patients developed distant metastases subsequent to the
initial diagnosis, first in lymph nodes and then in lungs
(A-07, D-12) and brain (U-25).
Melanoma tissue was obtained from large regional sub-
cutaneous metastases prior to initiation of chemotherapy.
The tumour specimens were processed in RPMI-1640 culture
medium at 4-C immiately after the surgery. Blood clots
and normal tissues were removed. The cleaned melanoma
tissue was divided into pieces of approximately 2mm3 or
0.2cm3. Xenografted tumours were established by implanting
the 2 mm3 pieces subcutaneously in athymic mce. His-
tological preparations or single-cell suspensions for biological
studies were prepared from the 0.2cm3 pieces.
CeUl lines
Permanent cell lines, one from each ofthe four patients, were
established in monolayer culture. Single-cell suspensions were
p ared by mechanial digation of xenografted
tumours in the first passage and seeded in 25 cm2 tissue
culture flasks containing 5 ml ofculture medium (RPMI-1640
medium containing 20% fetal calf serum, 250mg 1' penicil-
lin and 50mg1- streptomycin). The suspensions were
incubated at 3TC in a humidfied atmosphere of 5% carbon
dioxide in air. The cells attached to the bottom of the flasks,
and proliferation was initiated within 2 days. The cultures
were trypsinised (treatment with 0.05% trypsin/0.02% EDTA
solution at 37C for 2 min) and subcultured at confluence.
Murine fibroblasts contaminating the cultures were removed
by differential trypsinisation. Chromosome analysis revealed
that cultures in passage 30 were free from murie stromal
cells. The cultures showed slow and irregular growth during
the first 35 passages in vitro. The rate ofcell proliferation was
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Table I Tumour characteristics in donor patients
Patient age Breslow thickness Regional Distant
Tumour (Year) Patient sex Primary tumour (mm) metastases metastases
A-07 50 Male Upper limb 3.8 Subcutis Lymph node
Lymph node Lung
D-12 38 Female Trunk 8.3 Subcutis Lymph node
Lymph node Lung
R-18 45 Female Neck 7.4 Subcutis Subcutis
Lymph node Lymph node
U-25 49 Male Trunk 5.0 Subcutis Lymph node
Lymph node Brain
stable and reproducible beyond passage 50. Large stocks of
cells in passage 75 were frozen and stored in liquid nitrogen.
These stocks were verified to be free from Mycoplasma con-
tamination by using both the Hoechst fluorescence and
mycotrin methods.
The cellular parameters reported here were determined by
studies ofexponentially growing cultures in passages 75-100,
i.e. they were determined after stable, permanent cell lines
had been established. The cells were in this period cultured in
RPMI-1640 medium (25 mM HEPES and L-glutamine) sup-
plemented with 13% fetal calf serum, 250mg1I` penicillin
and 50 mg 1-' streptomycin. The cultures were incubated at
37C in a humidified atmosphere of 5% carbon dioxide in air
and subcultured three times a week.
Cell number doubling time was determined by seeding
5 x I04 cells in 80 cm2 tissue culture flasks and measuring
number of cells per flask as a function of time. Growth
fraction and cell loss factor were determined by observing 40
randomly selected cells in a 48 h period; fraction of cells
entering mitosis and the outcome of mitosis were registered
(Rofstad et al., 1980). Plating efficiency (PE) was measured
by seeding 100 cells in 25 cm2 tissue culture flasks coniing
approximately 1.0 x I05 heavily irradiated (30 Gy) feeder
cells. DNA index was determined by flow cytometry (see
below).
Xenografted tumours
Adult Balb/c nu/nu mice, bred at our research institute, were
used as host animals for xenografted tumours. The mice were
maintained under specific pathogen-free conditions at con-
stant temperature (24-26°C) and humidity (30-50%). Steril-
ised food and tap water were given ad libitum.
Approximately 3.5 x I0 cells in 10 gil of Ca2"- and Mg2+-
free Hanks' balanced salt solution (HBSS) were inoculated
intradermally in the flanks of the mice by using a 100gl1
Hamilton syringe. The cells were harvested from exponen-
tially growing cultures in passages 75-100 by trypsinisation.
The take rate was 100%. Tumour volume (V) was calculated
as V = x/6 x ab2, where a is the longer and b the shorter of
two perpendicular tumour diameters, measured with cal-
lipers. Volume doubling time, fraction of necrotic tissue,
fraction of cells in S-phase and treatment sensitivity were
determined for tumours with volumes within the range of
200-400 mm3. Tumour weight was determined immediately
after tumour excision and refers to the wet weight.
Histopathological examinations
Tumour samples were fixed in phosphate-buffered 4%
paraformaldehyde, dehydrated, embedded in paraffin casts,
cut in 6-gm-thick sections and stained. Haematoxylin and
eosin staining were used for ordinary histopathological
examinations and for measurement of fraction of necrotic
tissue. Standard immunoperoxidase procedures were used to
highlight vessels in donor patients' tumours and to visualise
extracellular matrix in xenografted tumours (Nagelhus &
Rofstad, 1993). Polyclonal rabbit anti-factor VIII
(Dakopatts), polyclonal rabbit anti-laminin (Serotec), poly-
clonal rabbit anti-fibronectin (Calbiochem) and monoclonal
mouse anti-type IV collagen (Dakopatts) were used as
primary reagents. The sections were stained by using
diaminobenzidine as substrate and haematoxylin for
counterstaining. Murine host cells in xenografted tumours
were identified by using the bisbenzimide staining technique
(Rygaard, 1987).
Vascular density was assessed at a magnification of x 200
by counting number of capillary profiles per field of view,
corresponding to 0.75 mm2. A structure was defined as a
countable capillary only if a lumen and at least one brown-
staining endothelial cell were identified. Volume fraction of
necrosis was determined by point counting (Solesvik et al.,
1982). Five fields of view, selected according to stringent
stereological criteria (Weibel, 1979), were analysed in each of
4-6 different tumour pieces from each patient.
Ultrastructural examinations
The ultrastructure of microvessels in xenografted tumours
was examined by transmission electron microscopy. Tumour
pieces were fixed in a cacodylate-buffered mixture of 1%
glutaraldehyde and 4% paraformaldehyde, post-fixed in
buffered 1% osmium tetroxide and dehydrated in graded
alcohol solutions. The tissue was embedded in Epon-
Araldite and polymerised at 80C. Ultrathin sections were
double stained with uranyl acetate and lead citrate.
Cell suspensions
Single-cell suspensions were prepared from donor patients'
tumours and xenografted tumours by using a standardised
mechanical and enzymatic procedure. The tumour tissue was
minced with crossed scalpels in cold HBSS prior to
enzymatic treatment at 37C for 2 h. The enzyme solution
consisted of 0.2% collagenase, 0.05% pronase and 0.02%
DNAse in HBSS. The fraction of contaminating diploid host
cells in the suspensions, determined by flow cytometry, was
low for both donor patients' tumours (<10%) and xeno-
grafted tumours (<1%). The fraction of morphologically
intact tumour cells, determined by trypan blue exclusion, was
always high (>80%). Cell aggregates were removed from the
suspensions by filtration through 30gm nylon mesh.
Floe cytometry
An Argus Skatron flow cytometer, equipped with an arch
lamp as excitation source, was used for measurements of
DNA histograms. Suspensions of clean cell nuclei were
prepared from single-cell suspensions and stained with pro-
pidium iodide according to the detergent-trypsin method
(Vindel0v et al., 1983). Excitation of propidium iodide was
accomplished by using the 546 nm mercury line. Fluorescence
was detected at wavelengths above 590 nm. Chicken and
trout red blood cells were used as internal reference stan-
dards. DNA index was calculated by using human lym-
phocytes as diploid reference. The DNA histograms were
analysed mathematically to determine the distribution ofcells
in the cell cycle (Dean & Jett, 1974).806 E.K. ROFSTAD
Treatment sensitii'itY
Single cells. kept in suspension in RPMI-1640 culture
medium at pH 7.4. were treated with radiation (2.0 Gy). heat
(43.5'C for 60min) or dacarbazine (1 x lO3jgml-' for
60 min). Radiation treatment was carried out under aerobic
conditions at room temperature at a dose rate of 3.4 Gy
mini'. The X-ray unit was operated at 220 kV. 20 mA and
with 0.5 mm copper filtration (Rofstad. 1992b). Heat treat-
ment was performed by using a thermostatically regulated
water bath. To avoid enhancement of the cell inactivation by
the enzymes used for the preparation of single-cell suspen-
sions. the cells were incubated at 37°C in an atmosphere of
5% carbon dioxide in air for 3 h prior to the heat exposure
(Rofstad. 1992a). Dacarbazine treatment was given by
incubating the cells at 37°C in an atmosphere of 5% carbon
dioxide in air in the presence of the drug. The cells were
washed in Ca2'- and Mg'+-free HBSS after treatment.
Cell survival was measured by using a soft-agar colony
assay (Courtenay & Mills. 1978). The two distinguishing
features of the assay are (a) the use of growth factors from
rat erythrocytes to enhance the PE and (b) the use of a
tissue-mimicking atmosphere of 3% oxygen. 5% carbon
dioxide and 92% nitrogen to increase the rate of cell pro-
liferation. Details of the procedure are reported elsewhere
(Rofstad et al.. 1987). Macrophages are the only host cells
that form colonies in the assay. The loosely packed mac-
rophage colonies were easily distinguished from the densely
packed melanoma colonies. Melanoma colonies containing
more than 50 cells were counted by using a stereomicroscope
(Rofstad et al., 1987). The PE of trypan blue excluding
melanoma cells was 10-25% (donor patients' tumours).
10-40% (xenografted tumours) and 80-95% (monolayer
cultures).
Angiogenesis
Tumour angiogenesis was assessed by using the intradermal
angiogenesis assay (Kreisle & Ershler. 1988; Runkel et al..
1991). Approximately 3.5 x I0- cells, harvested from cultures
in exponential growth, were inoculated intradermally in the
flanks of mice as described above. The skin around the
inoculation sites was removed at predetermined times after
the inoculation. The tumours were located with a dissecting
microscope, and angiogenesis was quantified by counting the
number of capillaries oriented toward the tumours. The
number of capillaries was corrected for the background,
determined after injection of 10tLI of HBSS. The tumours
were dissected free from the skin and weighed after the
capillaries were scored.
Metastatic pattern
Intradermal tumours. 30 of each of the four lines, were
initiated in 120 mice as described above. The tumours were
removed surgically as soon as the largest tumour diameter
attained 1Omm. and the wounds were closed with surgical
clips. The mice were killed and autopsied 6 months after the
primary tumour was removed or when they were moribund.
All organs were examined for macroscopic metastases.
Lungs, axial and inguinal lymph nodes. brain, kidneys.
Table n Growth and pathophysiological parameters of tumours in
donor patients
Necroticfraction S-phasefraction
Tumour (002 (%0) Vascular density
A-07 0o 5 18-26b 82-280f
D-12 6-22 11 -16 35- 196
R-18 0-12 6-12 17-158
U-25 15-43 4-9 21 -133
'Range of 4-6 different tumour pieces. bRange of 4-5 different
tumour pieces. 'Number ofcapillary profiles per field ofview. Range of
six different tumour pieces.
adrenal glands, pancreas and liver were subjected to his-
tological assessment of metastases. Ten sections from
different locations in each organ, prepared and stained with
haemotoxylin and eosin, as described above, were examined.
Statistical analisis
Statistical comparisons of data were performed by non-
parametric analysis using the Mann-Whitney U-test and the
Kruskal-Wallis H-test. A significance criterion of P<0.05
was used.
Results
MVetastatic pattern in donor patients
The location of the primary tumour and the metastatic pat-
tern differed between the four donor patients (Table I). All
patients developed regional metastases in subcutis and lymph
nodes and distant metastases in lymph nodes, irrespective of
the location of the primary tumour. The distant lymph node
metastases of the R-18 patient were particularly aggressive;
they occurred within the thorax and the abdomen and
invaded adjacent tissues. The patients died 16-48 weeks after
presentation. The causes of death resulted from distant
metastases involving lungs (A-07. D-12). lymph nodes (R-18)
and brain (U-25).
Histopathologv, growth andpathophksiologv ofdonor patients'
tumours
The donor patients' tumours were heterogeneous in general
histopathological appearance. The tissue showed a solid
growth pattern separated by a meshwork of fibrous septae.
The density of the meshwork and the thickness of the septae
differed substantially between tumour regions. Extensive
spatial heterogeneity with respect to cell type. cellular
pleomorphism. nuclear atypia. nucleolar prominence and
mitotic activity was also a characteristic feature of the tissue.
Significant differences between the four tumours were not
detected. They were all judged to be highly malignant by
histopathological critenra.
The donor patients' tumours were also heterogeneous in
growth and pathophysiological parameters (Table II). Frac-
tion of necrotic tissue, fraction of cells in S-phase and vas-
cular density differed between tumour regions and between
tumours. Tumours showing high vascular densities also
showed high fractions of cells in S-phase and vice versa. The
tumour sequence from high to low values of these parameters
was: A-07. D-12. R-18. U-25 [fraction of cells in S-phase:
A-07 vs D-12. D-12 vs R-18 (P<0.01). R-18 vs U-25
(P<0.05); vascular density: A-07 vs D-12. D-12 vs R-18
(P<0.05), R-18 vs U-25 (NS. P -0.1)]. There were no cor-
relations between vascular density or fraction of cells in
S-phase on the one hand and fraction of necrotic tissue on
the other. The fraction of necrotic tissue was significant in
most regions of the D-12 and U-25 tumours, but small or
zero in the A-07 and R-18 tumours.
Growth ofcell lines
The four cell lines were characterised by extensive cellular
pleomorphism. Most cells were polygonal or spindle shaped
and showed abundant cytoplasm and large irregular nuclei
with prominent nucleoli. DNA index differed significantly
between the cell lines, whereas most growth parameters were
similar (Table III). The cell lines were hyperdiploid: DNA
index ranged from 1.1 ± 0.1 to 1.8 ± 0.1. Growth fraction
was high (>90%) and cell loss factor was low (< Oo%)
during exponential growth. The cell lines formed easily
scorable colonies within 7-10 days after plating and showed
a high PE (>80%). Median cell cycle time dunrng exponen-
tial growth, calculated from cell number doubling time.
growth fraction and cell loss factor. was slightly longer forHUMAN MELANOMA XENOGRAFT MODELS 37
the R-18 and U-25 lines than for the A-07 and D-12 lines
(P<0.05).
Angiogenesis ofxenografted twnours
Inoculation of tumour cells evoked a strong angiogenic res-
ponse in the mice (Figure 1). Tumour weight and number of
capillarnes oriented towards the tumours increased with time
after inoculation (Figure 2). The rate of angiogenesis and the
increase in tumour weight with time were tumour line depen-
dent and paralleled one another. The sequence of the tumour
lines from high to low values of these two parameters was:
A-07, D-12, R-18, U-25 [tumour weight: A-07 vs D-12, D-12
vs R-18, R-18 vs U-25 (P<0.005); number of capillaries:
A-07 vs D-12, D-12 vs R-18 (P<0.01), R-18 vs U-25
(P<0.05)].
The angiogenic response was heterogeneous also for cells
of the same line (Figure 3). This heterogeneity was reflected
in the rate of angiogenesis and in the density of the neovas-
Table m Growth parameters ofcell lines
Line DNA index GF (%)° v (%)/b PE (%)c T, (h)d
A-07 1.8 ±0.X 90-loOf 0-1l( 80-10f 15-171
D-12 1.1± 0.1 95-100 0-5 90-100 15-17
R-18 1.4 ± 0.1 95-100 0-5 90-100 19-21
U-25 1.6± 0.1 90-100 0-10 80-100 19-21
8GF, growth fraction. b, cell loss factor. 'PE, platingefficiency. dT,
cell cycle time. erMean ± s.e. offive independent experiments. 'Range of
five independent experiments.
culature. The number of capillaries oriented towards the
tumours at day 7 after inoculation was used as a parameter
for the rate of angiogenesis (Figure 3a). The number of
capillaries oriented toward the tumours at tumour weights of
approximately 30 mg was used as a parameter for the density
ofthe neovasculature (Figure 3b). The latter parameter might
also reflect the capillary density within the 30mg tumours.
Histopathology, growth andpathophysiology ofxenografted
twnours
The xenografted tumours were deposited above the sub-
cutaneous muscle tissue in the deeper part of the dermis, and
were not circumscribed by a fibrous capsule (Figure 4a). The
dermis (Figure 4b) and the subcutaneous muscle (Figure 4c)
were infiltrated and gradually replaced by tumour tissue dur-
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ing tumour growth. Finally, the tumours penetrated the
epidermis and formed an ulcer. The histopathological
appearance of the tumour parenchyma was similar to that of
the donor patients' tumours. The extent of cellular pleomor-
phism and nuclear atypia differed between tumour regions
and individual tumours. Distit differences between the four
lines were not detected. Large tumours frequently developed
regions with corded growth. The cords, i.e. cylindrical struc-
tures of viable tumour cells surrounding functional vessels,
were sometimes separated completely by necrosis (Figure 4d).
The xenografted tumours developed a heterogeneous
stroma that showed clear histopathological similarities to the
stroma of the donor patients' tumours. The vascular network
consist of two distin types of microvessels: (a) normal
microvessels recruited from the pre-existing network in the
skin during tumour growth and (b) pathological microvessels
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Fagwe 3 Angiogenesis in athymic mice following intradermal
inoculation of 3.5 x I@0 human melanoma cells. a, Nwnber of
capillaries orented toward the tumours at day 7 after iocula-
tion. b, Number of capillares orinted toward the tumours at
tumour wet weights of approximately 30 mg Points, single
tumour inoculations.
recruited by tumour-induced neovascularisation. The normal
microvessels included terminal arterioles invested in vascular
smooth muscle, non-fenestrated capillaries and dilated post-
capillary venules. The neovasculature showed severe struc-
tural abnormalities including incomplete endothelial lining,
interrupted or absent basement membrane and/or lack of
pericytes. The extracellular matrix appeared in immunohis-
tochemical preparations as an irTegular meshwork, differing
considerably in structure and density between tumour regions
and individual tumours (Figure 5). Antibodies against
laminin, fibronectin and type IV collagen gave similar stain-
ing patterns. The infiltration of host cells in the tumours was
sparse; leucocytes, macrophages and fibroblasts constituted
less than 1% of the total number of cells. Sigifint
differences between the four lines in the appearance of the
stroma were not detected.
Quantitative analysis showed that tumour lines and indi-
vidual tumours of the same line differed substantially in
growth and pathophysiological parameters (Figure 6). The
differences were reflected in tumour volume doubling time,
fraction of necrotic tissue and fraction of cells in S-phase.
The sequence of the tumour lines from short to long volume
doubling times was equal to that from high to low fractions
ofcells in S-phase: A-07, D-12, R-18, U-25 [volume doubing
time: D-12 vs R-18 (P<0.01), A-07 vs D-12, R-18 vs U-25
(P<0.05); fraction ofcells in S-phase: A-07 vs D-12, D-12 vs
R-18 (P<0.05), R-18 vs U-25 (NS, P-0.2)]. There were no
correlations between volume doubling time or fraction of
cells in S-phase on the one hand and fraction of necrotic
tissue on the other. Fraction of necrotic tissue was significant
in most D-12 and U-25 tumours, but small or zero in A-07
and R-18 tumours.
Metastatic pattern ofxenografted tunours
The xenografted tumours showed organ-specific metastatic
patterns (Table IV). The orgn of preference for the
development of metastases were lungs for A-07 and D-12
tumours (Figure 7a), lymph nodes for R-18 tumours (Figure
7b) and brain for U-25 tumours (Figure 7c). A-07 tumours
grew faster and were more angiogenic than D-12 tumours,
but did not metastasise more frequently than D-12 tumours.
U-25 tumours grew more slowly and were less angiogenic
than A-07, D-12 and R-18 tumours, but were the only ones
that formed brain metastases. R-18 lymph node metastases
and U-25 brain metastases developed without the occurrence
of lung metastases. Approximately 15% of the mice
developed organ-specific metastases within 6 months after the
inoculation of the primary tumour. In addition, approx-
imately 10% of the mice developed abdominal metastases.
Different organs in the abdomen were involved, particularly
adrenal glands, pancreas, liver and kidneys (Figure 7d). In
contrast, xenografted tumours grown at subcutaneous sites
did not develop organ-specific or abdominal metastases.
Treatment sensitivity ofdonor patients' twnours, cell lines and
renografted tumours
The donor patient's tumour, the corresponding cell line and
the corresponding xenografted tumours showed similar sen-
sitivities to treatment in vitro, no matter which line or treat-
ment modality was considered (Table V). The sensitivity to a
given treatment differed substantially between the lines.
There were no correlations between the sensitivity to radia-
tion treatment, heat treatment and dacarbazine treatment.
The sequences of the lines from high to low cel surviving
fractions following treatment were: R-18, U-25, A-07, D-12
(radiation treatment); D-12, R-18, U-25, A-07 (heat treat-
ment); and U-25, A-07, R-18, D-12 (dacarbazine treatment).
Human tumour xenografts are supposed to be appropriate
models for addressing specific questions related to the clinical
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behaviour and treatment sensitivity of human tumours.
Several studies have suggested that fundamental biological
properties of the donor patients' tumours may be retained
after heterotransplantation, including expresion of proto-
oncogenes, tumour-associated antigens and receptors for
growth factors and hormones (Langdon & Smyth, 1991);
vascular and microenvironmental parameters (Vaupel et al.,
1987); sensitivity to drug, radiation and heat treatment (Steel
et al., 1983; Rofstad, 1989a); and growth pattern and metas-
tatic potential (Fidler, 1990). However, biological conditions
which may limit the usefulness of human tumour xenografts
in cancer research have also been recognised. Thus, the vas-
cular network and the blood of xenografted tumours
orginate from the host, a fact which may cause the oxygen
and nutrient supply to differ from that in tumours in man
(Solesvik et al., 1982). Moreover, immune reactions by the
host may be active against xenografted tumours and
artificially enhance the response to treatment (Rofstad,
1989b).
Research groups should endeavour to have available a
panel of xenograft lines of the same histopathological type
(Kallman et al., 1985; Sutherland et al., 1988; Rofstad, 1991).
The panel should be composed of lines which (a) have
retained essential biological features of the donor patients'
tumours, (b) show distinctly different biological characteris-
tics in the new host and (c) possess growth qualities making
them well suited for experimental studies in vivo and in vitro.
These recommendations are met by the melanoma xenograft
panel reported here.
Retention of biological characteristics in heterotrans-
planted human tumours may require the interaction of the
tumour cells with the relevant organ microenvironment
(Fxiler, 1990). Orthotopic inoculation seems to be particular-
ly imxportant for accurate reproduction of the metastatic
behaviour of human tumours (Fidler, 1991). Thus, intrader-
mal inoculation of human melanoma cells in athymic mice
resulted in primary tumours that metastasised at high fre-
quency to draining lymph nodes, wlhreas the primary
tumours that developed after subcutaneous inoculation ofthe
same cells rarely gave rise to lymph node meastases (Cornil
et al., 1989). Melanocytes are normally found in the der-
mal- rmal junction of the skin. Tumour growth in
orthotopec sites was achieved in the present work by int-
radermal inoculation ofmelanoma cells; intradermal inocula-
tion resulted in tumours that infiltrated the of the
mice within a short time.
Most reports dealing with retention of biological charac-
teristics in heterotransplanted human tumours refer to studies
of a single biological feature or a few closely related
biological phenomena. The biologicl prorties of the
xenografted tumours were usually compared with the general
clinical behaviour of tumours of the same histopathoogical
type. However, citical xamination requires measurement of
sveral unrelated biolgical parameters in donor patients'
tumours and derivative xenografted tumours, followed by
paired analysis of the data. This approach was used in the
present work.
Essential biological features of the donor patients' tumours
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z Fugwe 5 Immunohistochemical visualisation of the extracellular
matrix of human melanoma xenografted tumours growing intra-
dermaHly in athymic mice. a, Irregular fine-meshed network,
laminin staining of an R-18 tumour, x 80. b, Irregular coarse-
meshed network, laminin staining of an R-18 tumour, x 80.
30
20
10
0 Table IV Metastatic pattern ofxenografted tumours
Tumour Abdomn Lungs Lymph nodes Brain
A-07 3/30k 4/30 0/30 0/30
D-12 2/30 6/30 0/30 0/30
R-18 4/30 0/30 5/30 0/30
U-25 2/30 0/30 0/30 5/30
aFraction of mice with metastases.
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were found to be retained after the heterotransplantation.
Thus, xenografted tumours and donor patients' tumours
were similar in respect of general histopathological
appearance, fraction of necrotic tissue, fraction of cells in
S-phase and cellular sensitivity to radiation, heat and dacar-
bazine treatment. The tumour sequence from high to low
values of vascular and angiogenic parameters was equal in
mice and patients. Moreover, the organ-specific metastatic
pattern of the xenografted tumours reflected the pattern of
distant metastases in the donor patients, i.e. each individual
cell line generated xenografted tumours that recapitulated the
metastatic pattern of the donor tumour tissue. Consequently,
basic biological mechanisms relevant for the clinical be-
haviour and treatment sensitivity of malignant melanoma
may be revealed by the use of these melanoma xenograft
model systems in cancer research.
The four tumour lines showed distinctly different biological
characteristics, i.e. the intrinsic properties of the tumour cells
differed between the lines. This was reflected in the
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Figwe 6 Growth and pathophysiological parameters of human
melanoma xenografted tumours growing intradermally in athymic
mice. a, Tumour volume doubling time. b, Fraction of necrotic
tissue. c, Fraction of cells in S-phase. Points, single tumours.
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Table V Sensitivity to treatment
Cells Radiione Healh Dacarbazine
A-07
Patient's tumour (2.4 ± 0.5) x 10-Id (1.5 ± 0.8) x 10' (2.7 ± 0.8) x 10
Cell line (2.5 ± 0.4) x 10-' (1.6 ± 0.7) x 10-' (2.2 ± 0.9) x 10-
Xenograft (2.2±0.5)x 10' (l.9±0.9)x 10-' (2.8±0.7)x 10-'
D-12
Patient's tumour (1.5 ± 0.4) x 10' (7.5 ± 0.9) x 10' (4.9 ± 1.0) x 10-2
Cellhne (1.3 ±0.4) x 10- (7.4 ±0.6) x 10-' (4.0± 1.2) x 10-2
Xenograft (1.7 ± 0.5) x 10-' (7.0± 0.8) x 10-' (4.4±0.9) x 10-2
R-18
Patient's tumour (4.5 ± 0.7) x 10- (5.4 ± 0.7) x 10-' (8.1 ± 1.2) x 10-2
Cell lne (4.9 ±0.5) x 10-' (5.1 ±0.9) x 10-' (9.5 ± 1.3) x 10-2
Xenograft (4.4 ± 0.6) x 10-' (5.8 ± 0.8) x 10-' (8.9 ± 1.0) x 10-2
U-25
Patient's tumour (3.6 ± 0.6) x 10-' (3.7 ± 0.9) x 10-' (6.0 ± 1.0) x 10-'
Cellfine (3.1 ±0.7) x 10-' (3.9 0.8) x 10-1 (6.9 0.8) x 10-'
Xenograft (3.9 ± 0.8) x 10- (3.3 ± 0.6) x 10-1 (6.4 ± 0.8) x 10-1
aSurvivingfractionafter 2.0 Gy in vitro. bSurvivingfractionafter 43.5C for 60min in
vitro. 'Surviving fraction after I x 10 ygml-' for 60 m in vitro. dMean ± s.e. of4-7
independent epernts.
a b
d
Fuge 7 Histopathological appearance of metastases from human melanoma xenografted tumours growing intradermally in
athymic mice. a, Lung metastasis from an A-07 tumour, x 160. b, Lymph node meastasis from an R-18 tumour, x 160. c, Brain
metastasis from a U-25 tumour, x 80. 4, Kidney meastass from a D-12 tumour, x 80.
angiogenic potential, growth and pathophysiological para-
meters, the sensitivity to treatment and the organ specificity
of the metastatic pattern. It should be emphasised that R-18
lymph node metastases and U-25 brain metastases developed
without lung involvement. The melanoma xenograft panel
thus represents a valuable tool for studies of genetic factors
and molecular mechanisms governing the biology of malig-
nant melanoma.
Moreover, individual tumours of the same line differed
substantially in pathophysiological parameters, probably as a
consequence of differences between inoculation sites in host
factors which influence tumour angiogenesis. Tumour treat-
ment sensitivity and metastatic potential are strongly affected
by blood flow, oxygen and nutrient supply, microen-
vironmental conditions and bioenergetic status (Folkman,
1985; Sutherland et al., 1988; Vaupel et al., 1989; Hill, 1990).
The melanoma xenograft model systems may thus be utilised
to establish correlations between pathophysiological para-
meters and parameters characterising tumour treatment res-
ponse or metastatic behaviour, and to investigate whether
correlations are valid across tumour lines or whether different
correlations exist for tumour lines differing in intrinsic cel-312 E.K. ROFSTAD
lular properties (Rofstad et al., 1988). The development of in
vitro and/or in vivo assays for prediction of response to
treatment or metastatic behaviour of malignant melanoma
may be guided by investigations of this type (Rofstad,
1989c).
Xenografted tumours and monolayer cell cultures showed
growth properties and treatment sensitivities that render a
wide variety of experiments possible. Cell lines evoking a
strong angiogenic response in vivo formed tumours with short
volume doubling times and high fractions of cells in S-phase
and vice versa. Disaggregated xenografted tumours deve-
loped easily scorable colonies at high PE in vitro. The
established cell lines showed short cell cycle times, growth
fractions close to 100% and negligible cell loss factors during
exponential growth. Cellular sensitivity to radiation, heat and
dacarbazine treatment was similar for xenografted tumours
and monolayer cell cultures. Consequently, studies of xeno-
grafted tumours and monolayer cell cultures may comple-
ment one another in attempts to acquire increased knowledge
of the biology of malignant melanoma.
In conclusion, the melanoma xenograft panel reported here
is composed of tumour lines which have retained essential
biological features of the donor patients' tumours, show
distinctly different biological characteristics and possess
growth qualities making them well suited for experimental
studies in vivo and in vitro. The four orthotopic tumour
model systems thus show great promise for future studies of
tumour angiogenesis, pathophysiology, treatment sensitivity
and metastatic pattern.
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